To be the first to market statin/epa combo and to extend Lipitor patents. This could be worth 10s of billion for PFE.
Sentiment: Strong Buy
OMTH deal puts pressure now on PFE or GSK now. But PFE imo will be uiltimately the acquirer as GSK already had Lovaza
l.o.l you are joking right
It makes perfect sense to do it. Why let AZN be the first and allowing Lipitor to go generic?